Dr. Holtgrave's research has focused on the effectiveness and cost-effectiveness of a variety of HIV prevention interventions (including the provision of housing as a structural HIV/AIDS intervention), and the relationship of the findings of these studies to HIV prevention policy making. He has served on an Institute of Medicine panel charged with recommending methods to improve the public financing and delivery of HIV care in the United States. He has also previously served as the Director of the Division of HIV/AIDS Prevention -- Intervention Research & Support at the US Federal Centers for Disease Control and Prevention (CDC).

Dr. Holtgrave has also investigated the relationship between social capital measures, infectious disease rates, and risk behavior prevalence. He has worked extensively on HIV prevention community planning, and has served as a member of the Wisconsin HIV Prevention Community Planning group.

More recently, Dr. Holtgrave has begun to conduct economic evaluations of interventions designed to reduce smoking behaviors.

HIV/AIDS; HIV prevention; cost-effectiveness analysis; technology transfer; economic evaluation and smoking behavior

Member, Baltimore City AIDS Commission

Member, Presidential Advisory Council on HIV/AIDS

Member, Delta Omega Honorary Public Health Society, 2006

Student Government Association Professor of the Year, Rollins School of Public Health, Emory University, 2005

Woodruff Leadership Academy Fellow, Woodruff Health Sciences Center, Emory University, 2004

Appointed to Senior Biomedical Research Service, Centers for Disease Control and Prevention, 1997

C. Everett Koop National Health Award, The Health Project, 1996

Wolitski RJ, Kidder DP, Pals SL, Royal S, Aidala A, Stall R, Holtgrave DR, Harre D, Courtenay-Quirk C for the Housing and Health Study Team. Randomized trial of the effects of housing assistance on the health and risk behaviors of homeless and unstably housed people living with HIV. AIDS & Behavior, Epub ahead of print.

Holtgrave DR. Apparent declines in the global HIV transmission rate. International Journal of STD and AIDS 2009;20:876-878.

Holtgrave DR, Wunderink KA, Vallone DM, Health CG. Cost-utility analysis of the nation truth(r) campaign to prevent youth smoking. American Journal of Preventive Medicine 2009;36:385-388.

Holtgrave DR, Hall HI, Rhodes RH, Wolitski RJ. Updated annual HIV transmission rates in the United States, 1977-2006. Journal of Acquired Immune Deficiency Syndromes 2009;50:236-238.

Bleakley A, Fishbein M, Holtgrave DR. An assessment of the relationship between condom labels and HIV-related beliefs and intentions. AIDS & Behavior 2008;12:452-458.

Holtgrave DR. Evidence-based efforts to prevent HIV infection: An overview of current status and future challenges. Clinical Infectious Diseases 2007;45:S293-S299.

Holtgrave DR. When "heightened" means "lessened":The case of HIV prevention resources in the United States. Journal of Urban Health 2007;84:648-652.

Holtgrave DR. Costs and consequences of the US Centers for Disease Control and Prevention's recommendation for opt-out HIV testing. PLoS Medicine 2007;4:e194 (online electronic journal)

Holtgrave DR, Kates J. HIV incidence and CDC's HIV prevention budget: An explatory correlational analysis. American Journal of Preventive Medicine. Epub ahead of print, 2006 Dec.

Holtgrave DR, Pinkerton SD. Can increasing awareness of HIV seropositivity reduce HIV incidence by 50%? Journal of Acquired Immune Deficiency Syndromes. Epub ahead of print, 2006 Dec.

Holtgrave DR. Resilient organizations, mobilized communities, and evidence-based HIV prevention programs: Examining the influence of a national investment in HIV/AIDS capacity building. Journal of Public Health Management and Practice. 13(Supplement 1): S1-S4, 2007 Jan.

Holtgrave DR. Curran JW. What Works, and What Remains to Be Done, in HIV Prevention in the United States. Annual Review of Public Health. 27:261-275, 2006.

Holtgrave DR. Causes of the Decline in AIDS Deaths, United States, 1995-2002: Prevention, Treatment or Both? International Journal of STD & AIDS. 16(12)777-781, 2005 Dec.

Holtgrave DR. Crosby RA. Is Social Capital a Protective Factor Against Obesity and Diabetes? Findings from an Exploratory Study. Annals of Epidemiology. 16(5):406-408, 2006 May.

Holtgrave DR. Using Economic Threshold Analysis to Determine the Intensity of HIV Prevention Services for HIV Seropositive Persons. AIDS. 19(17):2025-2039, 2005 Nov.

Crosby RA, Holtgrave DR. Will Sexual Risk Behavior Increase After Being Vaccinated For AIDS? International Journal of STD & AIDS. 17(3):180-184, 2006 Mar.

Salazar L, Crosby RA, Holtgrave DR, Frew P, Peterson J. Issues related to gay and bisexual men's acceptance of a future AIDS vaccine. International Journal of STD & AIDS. 16(8):546-548, 2005 Aug.

Crosby RA, Holtgrave DR. The protective value of social capital against teen pregnancy: A state-level analysis. Journal of Adolescent Health. 38(5): 556-559, 2006 May.

Holtgrave DR. Anderson T. Utilizing HIV transmission rates to assist in prioritizing HIV prevention services. International Journal of STD & AIDS. 15(12):789-92, 2004 Dec.

Holtgrave DR. HIV-AIDS in the US: Three policy issues. Evidence-Based Healthcare & Public Health. 9:4-6, 2005.

Holtgrave DR. HIV prevention, cost-utility analysis, and race/ethnicity: Methodological considerations and recommendations. Medical Decision Making 24(2):181-191, 2004.